Pfizer Says Data Show COVID-19 Vaccine Triggers Immune Response in Children

Syringes and vials of the Pfizer-BioNTech COVID-19 vaccine are prepared to be administered at a drive up vaccination site from Renown Health in Reno, Nev. on Dec. 17, 2020. Patrick T. Fallon/AFP via Getty Images

Data from a clinical trial show that Pfizer’s COVID-19 vaccine triggers a strong immune response in children between the ages of 5 and 11, the company and its German partner said on Sept. 20.

The shot also had a favorable safety profile in the age group in the phase 2/3 trial, according to a summary of the trial data released by Pfizer and BioNTech.